SCHEMBL7765004

SCHEMBL7765004

CC(C)(SC(c1ccccc1)(c1ccccc1)c1ccccc1)[C@H]1C[C@@H](CSC(c2ccccc2)(c2ccccc2)c2ccccc2)C(=O)O1

nearest known ligand 0.33

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
KIF11 P52732 8/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7767445 0.73 CRBN (0.42)
SCHEMBL7313446 0.72 HTT (0.39) KIF11
SCHEMBL7307081 0.72 HTT (0.39) KIF11
SCHEMBL7764976 0.70 TNKS (0.32)
SCHEMBL7310163 0.68 HTT (0.54)
SCHEMBL7315945 0.68 HTT (0.54)
SCHEMBL18742139 0.66 KIF11 (0.37) KIF11
SCHEMBL7767450 0.64 CRBN (0.41)
SCHEMBL17859347 0.63 KIF11 (0.46) KIF11
SCHEMBL7767482 0.63 CRBN (0.48)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0639566-B1 CYCLIC COMPOUND SANTEN PHARMACEUTICAL CO LTD (JP) 2001-06-20 EP disclosed
US-5461158-A Immunodeficiency and autoimmune diseases SANTEN PHARMACEUTICAL CO., LTD. (JP) 1995-10-24 US disclosed
EP-0639566-A1 CYCLIC COMPOUND SANTEN PHARMACEUTICAL CO., LTD. (JP) 1995-02-22 EP disclosed